CN105130862A - 1,3-bis(4-cyano-3-trifluoromethylphenyl)thiourea preparation method - Google Patents

1,3-bis(4-cyano-3-trifluoromethylphenyl)thiourea preparation method Download PDF

Info

Publication number
CN105130862A
CN105130862A CN201510482191.4A CN201510482191A CN105130862A CN 105130862 A CN105130862 A CN 105130862A CN 201510482191 A CN201510482191 A CN 201510482191A CN 105130862 A CN105130862 A CN 105130862A
Authority
CN
China
Prior art keywords
preparation
mole
trifluoromethyl
thiocarbamide
cyano group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510482191.4A
Other languages
Chinese (zh)
Inventor
顾喜丰
张浩波
徐骏
陆明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHEMFUTURE PHARMATECH (JIANGSU) Ltd
Original Assignee
CHEMFUTURE PHARMATECH (JIANGSU) Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHEMFUTURE PHARMATECH (JIANGSU) Ltd filed Critical CHEMFUTURE PHARMATECH (JIANGSU) Ltd
Priority to CN201510482191.4A priority Critical patent/CN105130862A/en
Publication of CN105130862A publication Critical patent/CN105130862A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to the field of chemistry, and discloses a 1,3-bis(4-cyano-3-trifluoromethylphenyl)thiourea preparation method, which comprises: 1, adding 1 mole of 4-amino-2-trifluoromethyl benzonitrile, 1-2.2 mole of diisopropylethylamine and 50 ml of dichloromethane to a reaction bottle; 2, adjusting the reaction system temperature to 20 DEG C, and adding 0.5 mole of thiophosgene in a dropwise manner; 3, controlling the reaction system to react for 2-3 h at a temperature of 20 DEG C; and 4, drying, and filtering the reaction solution to obtain the 1,3-bis(4-cyano-3-trifluoromethylphenyl)thiourea. According to the present invention, the preparation method has characteristics of reasonable synthesis route, cheap and easily available raw materials, simple and easy-performing operation, high yield and product purity meeting the requirement.

Description

The preparation method of two (4-cyano group-3-trifluoromethyl) thiocarbamide of 1,3-
Technical field
The invention belongs to pharmaceutical synthesis field, be specifically related to the preparation method of two (4-cyano group-3-trifluoromethyl) thiocarbamide of 1,3-.
Background technology
1, two (4-cyano group-3-trifluoromethyl) thiocarbamide of 3-is the major impurity that grace is mixed in Shandong amine (enzalutamide) building-up process, grace Shandong amine of mixing is developed cooperatively by Medivation company and Astellas (Astellas) company, chemical name is 4-[ 3-(4-cyano group-3-trifluoromethyl)-5,5-dimethyl-4-oxo-2-thiocarbamoyl imidazole alkane-1-base ] the fluoro-N-methyl-benzamide of-2-.Grace mix Shandong amine in Nikkei FDA (Food and Drug Adminstration) August 31 in 2012 (FDA) approval be used for the treatment of spread or recur late period male sex's castration tolerate prostate cancer (castration-resistantprostatecancer), commodity are called Xtandi, and this medicine is oral preparations.
Mix according to current synthesis grace the technique of Shandong amine, inevitably produce two (4-cyano group-3-trifluoromethyl) this impurity of thiocarbamide of 1,3-, the structural formula of two (4-cyano group-3-trifluoromethyl) thiocarbamide of 1,3-is:
By synthesizing this material and sample can effectively carry out in the analysis of foreign matter content grace Shandong amine of mixing as a comparison, but not yet there is its synthetic method of bibliographical information at present.
Summary of the invention
The problem of prior art in view of the above, the invention provides a kind of preparation method of 1,3-two (4-cyano group-3-trifluoromethyl) thiocarbamide that operation is simple.
Preparation method comprises the following steps:
(1) in reaction flask, the 4-amino-2-4-trifluoromethylbenzonitrile of 2 moles is added, the diisopropylethylamine of 2-4.4 mole and 50ml methylene dichloride;
(2), after temperature of reaction system being adjusted to 20 DEG C, the thiophosgene of 0.5 mole is dropped to;
(3) control reaction system and react 2-3 hour at 20 DEG C;
(4) dry, filtering reacting solution obtains two (4-cyano group-3-trifluoromethyl) thiocarbamide of 1,3-.
Preferably, step (3) also comprises employing HPLC tracking reaction until two (4-cyano group-3-trifluoromethyl) thiocarbamide of 1,3-no longer increases.
Preferably, in step (4), dry, filtering reacting solution, comprises the following steps: in reaction system, add 20ml water carry out layering, filters and obtains organic layer solution, organic over anhydrous dried over sodium sulfate 4h, filter vacuum concentrates dry doubling ethyl alcohol recrystallization the most at last.
Preferably, described step (1) adds the amount of diisopropylethylamine is 1-1.5 mole.
Prepared by aforesaid method 1,3-two (4-cyano group-3-trifluoromethyl) thiocarbamide, molar yield is 70%, purity is 99%.
The invention provides the preparation method of two (4-cyano group-3-trifluoromethyl) thiocarbamide of 1,3-, 4-amino-2-4-trifluoromethylbenzonitrile , diisopropylethylamine DIPEA/CH 2cl 2with thiophosgene SCl 2two (4-cyano group-3-trifluoromethyl) thiocarbamide of Reactive Synthesis 1,3- ,
Synthetic route is as follows:
Accompanying drawing explanation
Fig. 1 is shown as 1,3-two (4-cyano group-3-trifluoromethyl) thiocarbamide nmr spectrum prepared by the present invention.
Embodiment
Below by way of specific specific examples, embodiments of the present invention are described, those skilled in the art the content disclosed by this specification sheets can understand other advantages of the present invention and effect easily.The present invention can also be implemented or be applied by embodiments different in addition, and the every details in this specification sheets also can based on different viewpoints and application, carries out various modification or change not deviating under spirit of the present invention.It should be noted that, when not conflicting, the embodiment in the application and the feature in embodiment can combine mutually.Embodiment is a kind of preferred version of the present invention, not does any pro forma restriction to the present invention, also has other variant and remodeling under the prerequisite not exceeding the technical scheme described in requirement.
3.72g(2mmol is added in reaction flask) Compound II per, 2.71g(2.1mmol) diisopropylethylamine, 50ml methylene dichloride, is cooled to 20 DEG C, drips 1.14g(1mmol) thiophosgene.Be 20 DEG C in temperature to react 2 ~ 3 hours, HPLC follows the tracks of reaction until Compound II per reacts completely, 20ml water is added to reaction solution, layered filtration, organic over anhydrous dried over sodium sulfate 4h, by concentrated for filter vacuum dry, 20ml ethyl alcohol recrystallization obtains 1 of 2.9g, two (4-cyano group-3-trifluoromethyl) thiocarbamide of 3-, molar yield is 70%, purity is 99%.
Show in accompanying drawing 1:
Product 1h-NMR (400MHz, CDCl3) δ: 9.56 (s, 2H), 8.20 (d, J=2Hz, 2H), 7.98 (d, J=2Hz, 2H), 7.83 (d, J=8.4Hz, 2H) ppm.
Last it is noted that the foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.

Claims (4)

  1. The preparation method of two (4-cyano group-3-trifluoromethyl) thiocarbamide of 1.1,3-, is characterized in that, comprise the steps:
    (1) in reaction flask, the 4-amino-2-4-trifluoromethylbenzonitrile of 2 moles is added, the diisopropylethylamine of 2-4.4 mole and 50ml methylene dichloride;
    (2), after temperature of reaction system being adjusted to 20 DEG C, the thiophosgene of 0.5 mole is dropped to;
    (3) control reaction system and react 2-3 hour at 20 DEG C;
    (4) dry, filtering reacting solution obtains two (4-cyano group-3-trifluoromethyl) thiocarbamide of 1,3-.
  2. 2. preparation method according to claim 1, is characterized in that, step (3) also comprises employing HPLC and follows the tracks of reaction until two (4-cyano group-3-trifluoromethyl) thiocarbamide of 1,3-no longer increases.
  3. 3. preparation method according to claim 1, it is characterized in that, dry, filtering reacting solution in step (4), comprise the following steps: in reaction system, add 20ml water carry out layering, filtration obtains organic layer solution, organic over anhydrous dried over sodium sulfate 4h, filter vacuum concentrates dry doubling ethyl alcohol recrystallization the most at last.
  4. 4. the preparation method according to any one of claims 1 to 3, is characterized in that, the amount adding diisopropylethylamine in described step (1) is 1-1.5 mole.
CN201510482191.4A 2015-08-10 2015-08-10 1,3-bis(4-cyano-3-trifluoromethylphenyl)thiourea preparation method Pending CN105130862A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510482191.4A CN105130862A (en) 2015-08-10 2015-08-10 1,3-bis(4-cyano-3-trifluoromethylphenyl)thiourea preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510482191.4A CN105130862A (en) 2015-08-10 2015-08-10 1,3-bis(4-cyano-3-trifluoromethylphenyl)thiourea preparation method

Publications (1)

Publication Number Publication Date
CN105130862A true CN105130862A (en) 2015-12-09

Family

ID=54716498

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510482191.4A Pending CN105130862A (en) 2015-08-10 2015-08-10 1,3-bis(4-cyano-3-trifluoromethylphenyl)thiourea preparation method

Country Status (1)

Country Link
CN (1) CN105130862A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106478477A (en) * 2015-08-26 2017-03-08 四川科伦药物研究院有限公司 Grace miscellaneous Shandong amine midbody compound and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106478477A (en) * 2015-08-26 2017-03-08 四川科伦药物研究院有限公司 Grace miscellaneous Shandong amine midbody compound and preparation method thereof

Similar Documents

Publication Publication Date Title
CN105107545B (en) The application of ionic-liquid catalyst
CN103880822B (en) Containing 2,4,6-trisubstituted pyrimidine compounds of 1,2,3-triazole, preparation method and application thereof
CN103553857A (en) Method for preparing o-trifluoromethyl phenylamine and derivatives thereof
CN104530033A (en) Novel process method for preparing arotinolol hydrochloride
CN103588765B (en) The synthetic method of the synthetic method of Azilsartan or its salt and intermediate and intermediate
CN105330560A (en) Enzalutamide intermediate preparation method
CN105130862A (en) 1,3-bis(4-cyano-3-trifluoromethylphenyl)thiourea preparation method
CN102796134B (en) Preparation method for Maxacalcitol intermediate
AU2016269359B2 (en) Sodium salt of uric acid transporter inhibitor and crystalline form thereof
KR102366890B1 (en) Method for producing iron complex and method for producing ester compound using iron complex
CN104829553A (en) New method of synthesizing 2,4-di-substituted benzothiazole
CN104926900A (en) Method for preparing Capecitabine intermediate represented by formula I
CN112358467B (en) Preparation process of pyrroltinib
CN105237481B (en) A kind of method of rare earth catalyst synthesis 1,4,5,6- tetrahydropyrimidinederivatives derivatives
CN103992303B (en) Prepare the method for 2-triazole-Cinchonic Acid's compound
CN103588764B (en) The synthetic method of Azilsartan or its salt and intermediate thereof
CN103254175A (en) Preparation method of nilotinib
CN111892533A (en) Regorafenib related substance, and preparation method and application thereof
CN103664706A (en) Method for preparing guanidino compounds by hydrogen cyanamide
CN105237432B (en) The synthetic method of N, N di-2-ethylhexylphosphine oxide benzamide compound
CN104151185A (en) N-(2,4-dimethyl phenyl)-3-hydroxyl-2-naphthamide and preparation method thereof
CN105924400B (en) The preparation method of Azilsartan impurity A and B
CN104387329A (en) Method for synthesizing intermediate methyl 2-(2-(6-chloropyrimidine-4-yl-oxo)phenyl) acetate
CN102964310A (en) Preparation method of 2-position substituted imidazole
CN103275069B (en) Preparation method of cediranib

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151209

WD01 Invention patent application deemed withdrawn after publication